IL28B polymorphisms, IP-10 and viral load predict virological response to therapy in chronic hepatitis C
ContributorsFattovich, Giovanna; Covolo, L; Bibert, S; Askarieh, G; Lagging, M; Clément Leboube, Sophie; Malerba, G; Pasino, M; Guido, M; Puoti, M; Gaeta, G B; Santantonio, T; Raimondo, G; Bruno, R; Bochud, P-Y; Donato, F; Negro, Francesco; ITAHEC Study Group
Published inAlimentary Pharmacology and Therapeutics, vol. 33, no. 10, p. 1162-1172
Publication date2011
Abstract
Keywords
- Adult
- Antiviral Agents/therapeutic use
- Chemokine CXCL10/blood
- Cohort Studies
- Drug Therapy
- Combination
- Enzyme-Linked Immunosorbent Assay
- Female
- Genotype
- Hepacivirus/genetics
- Hepatitis C
- Chronic/blood/drug therapy/genetics
- Humans
- Interferon-alpha/therapeutic use
- Interferons
- Interleukins/genetics
- Male
- Middle Aged
- Polyethylene Glycols/therapeutic use
- Polymorphism
- Genetic
- Prospective Studies
- RNA
- Viral/blood
- Recombinant Proteins/therapeutic use
- Ribavirin/therapeutic use
- Viral Load
Research groups
Citation (ISO format)
FATTOVICH, Giovanna et al. IL28B polymorphisms, IP-10 and viral load predict virological response to therapy in chronic hepatitis C. In: Alimentary Pharmacology and Therapeutics, 2011, vol. 33, n° 10, p. 1162–1172. doi: 10.1111/j.1365-2036.2011.04635.x
Main files (1)
Article (Published version)
Identifiers
- PID : unige:152345
- DOI : 10.1111/j.1365-2036.2011.04635.x
- PMID : 21443535
Journal ISSN0269-2813
